Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Research Stage: Tirzepatide is approved
They rarely get better
It promotes angiogenesis and reduces inflammation, creating the conditions necessary for healing to begin
Our results indicated that neither GHK nor GHK-Cu showed cytotoxic activity at the range of concentrations tested while CuCl 2 and Cu(OAc) 2 showed substantial cytotoxicity to the HaCaT cells at the highest concentration assayed, i.e., at 5800 M, after 30 mins treatment
In a randomized, double-blind trial where women applied GHK-Cu encapsulated in a nano-lipid carrier twice daily for 8 weeks, the treatment group saw significant improvements in wrinkle depth and volume with no serious adverse events
